scholarly journals Cost-Effectiveness of Once-Daily, Single-Inhaler Indacaterol Acetate/ Glycopyrronium Bromide/ Mometasone Furoate in Patients with Uncontrolled Moderate-to-Severe Asthma in Canada

2021 ◽  
Vol Volume 13 ◽  
pp. 957-967
Author(s):  
Mondher Mtibaa ◽  
Subhajit Gupta ◽  
Madhusubramanian Muthukumar ◽  
Jessica Marvel ◽  
Harneet Kaur ◽  
...  
Keyword(s):  
Cost Effectiveness ◽  
Severe Asthma ◽  
Mometasone Furoate ◽  
Once Daily ◽  
Glycopyrronium Bromide

scholarly journals Lung Function Normalisation with Indacaterol Acetate/Glycopyrronium Bromide/Mometasone Furoate in Patients with Asthma

2021 ◽  
Author(s):  
Kenneth R. Chapman ◽  
Henrik Watz ◽  
Dave Singh ◽  
Jens M. Hohlfeld ◽  
Zuzana Diamant ◽  
...  
Keyword(s):  
Lung Function ◽  
Mometasone Furoate ◽  
Glycopyrronium Bromide

Indacaterol acetate, glycopyrronium bromide, and mometasone furoate: effect on neuronal inflammation and acetylcholine release

2021 ◽  
Author(s):  
Paola Rogliani ◽  
Beatrice Ludovica Ritondo ◽  
Francesco Facciolo ◽  
Maria Gabriella Matera ◽  
Ivan Nikolaev ◽  
...  
Keyword(s):  
Acetylcholine Release ◽  
Mometasone Furoate ◽  
Glycopyrronium Bromide

scholarly journals Cost-effectiveness analysis of a state funded programme for control of severe asthma

2007 ◽  
Vol 7 (1) ◽  
Author(s):  
Rosana Franco ◽  
Andreia C Santos ◽  
Harrison F do Nascimento ◽  
Carolina Souza-Machado ◽  
Eduardo Ponte ◽  
...  
Keyword(s):  
Cost Effectiveness ◽  
Severe Asthma ◽  
Cost Effectiveness Analysis ◽  
Effectiveness Analysis

scholarly journals Cost-effectiveness of omalizumab in adults with severe asthma: Results from the Asthma Policy Model

2007 ◽  
Vol 120 (5) ◽  
pp. 1146-1152 ◽  
Author(s):  
Ann C. Wu ◽  
A. David Paltiel ◽  
Karen M. Kuntz ◽  
Scott T. Weiss ◽  
Anne L. Fuhlbrigge
Keyword(s):  
Cost Effectiveness ◽  
Severe Asthma ◽  
Policy Model
Sign in / Sign up

Export Citation Format

Share Document